In our study, initially several important single nucleotide polymorphisms (SNPs) in STAT3 (including rs2293152, rs6503695, and rs12949918), which have been associated with gene expression and lymphoma risk [10,11], were analyzed in 166 peripheral blood specimens from DLBCL patients treated with rituximab. Here, STAT3 is linked to lymphoma.